Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - avonex
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp36f1b29a7444210831ac7deab30ae673
identifier: http://ema.europa.eu/identifier
/EU/1/97/033/003
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: AVONEX 30 micrograms/0.5 ml solution for injection.
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-36f1b29a7444210831ac7deab30ae673
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/97/033/003
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - avonex
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
on a regular basis Do not stop your Avonex treatment without speaking to your doctor. Avonex can help to reduce the number of relapses that you have and slow down the disabling effects of MS. Your doctor will advise you for how long you can use Avonex or when to stop. How AVONEX works Multiple sclerosis is linked to nerve (brain or spinal cord) damage. In MS, your body s defence system reacts against its own myelin the insulation that surrounds nerve fibres. When myelin is damaged, the messages between the brain and other parts of the body are disrupted. This is what causes the symptoms of MS. Avonex seems to work by stopping your body s defence system from attacking the myelin.
If you are having a blood test. Avonex may interfere with the results. (Notes information) Sometimes you will need to remind other medical staff that you are being treated with Avonex. For example, if you are prescribed other medicines, or if you have a blood test, Avonex may affect the other medicines or the test result. Paediatric population Avonex is not recommended for use in children and adolescents because there is limited data on the use of Avonex in this population. Avonex should not be used in children below 10 years of age because it is yet to be established whether it would work for them and whether it would be safe. Other medicines and AVONEX Tell your doctor if you are using, have recently used or might use any other medicines, especially those used to treat epilepsy or depression. Avonex may affect other medicines or be affected by them. This includes any other medicines including medicines obtained without a prescription. Pregnancy and breast-feeding If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. No harmful effects on the breastfed newborn/infant are anticipated. Avonex can be used during breast- feeding. Driving and using machines If you feel dizzy, do not drive. Avonex makes some people feel dizzy. If this happens to you, or if you get any other side effects that could affect your ability, do not drive or use machines. Important information about some of the ingredients of AVONEX This medicine is essentially sodium-free . It contains less than 23 mg (1 mmol) sodium in each weekly dose.
The recommended weekly dose One injection of Avonex, once a week. Try to use Avonex at the same time on the same day each week. If you have decided to start treatment with Avonex, your doctor may provide you with an Avostartclip titration kit. The Avostartclip attaches to the syringe and enables you to gradually increase your dose of Avonex when you first start treatment. This is to limit flu-like symptoms which some people experience when they start using Avonex. Your doctor or nurse will help you use the Avostartclip titration kit. (Notes information) Starting Avonex If you are new to Avonex, your doctor may advise you to gradually increase your dose so that you can adjust to the effects of Avonex before taking the full dose. You will be provided with an Avostartclip titration kit. Avostartclips can be attached onto the syringe enabling a reduced dose of Avonex to be injected at the start of treatment. Each Avostartclip should be used once and then discarded along with any remaining Avonex. For further details on use, speak with your doctor.
Injecting yourself You can inject Avonex yourself without the help of your doctor, if they have trained you to do this. The instructions on how to inject yourself are at the end of this leaflet (see section 7, How to inject AVONEX). If you have trouble handling the syringe, ask your doctor who may be able to help. (Notes information) There are more details on how to inject Avonex at the end of this leaflet. Alternate needle: Your pack of Avonex already includes a needle for injection. It may be possible for your doctor to prescribe you a shorter and thinner needle, depending on your body type. Talk to your doctor to see if this is appropriate for you. If you have problems handling the syringe, talk to your doctor about using a syringe grip. This is a specially designed holder to help you with injecting Avonex. How long to use AVONEX Your doctor will tell you how long you need to keep using Avonex. It is important to continue using Avonex regularly. Do not make changes unless your doctor tells you. If you inject more than you should You should only have one injection of Avonex, once a week. If you have used more than one injection of Avonex in a three-day period, contact your doctor or pharmacist straight away for advice. If you miss an injection If you miss your usual weekly dose, inject a dose as soon as you can. Then leave a week before using Avonex again. Continue injecting on this new day every week. If you have a preferred day for using Avonex, talk to your doctor about managing the dose, to get back to your preferred day. Do not use two injections to make up for a missed injection.
If you notice any irritation or skin problems after an injection, talk to your doctor. Flu-like symptoms (Notes information) Three simple ways to help reduce the impact of flu-like symptoms:
Chills or a fever. These symptoms are not really flu You can t pass it on to anyone else. They are more common when you first start using Avonex. Your doctor may provide you with an Avostartclip titration kit which enables you to gradually increase your dose at the start of treatment to help limit flu-like symptoms. As you keep using your injections, the flu-like symptoms gradually decrease. Children (10 years of age and above) and adolescents In clinical trials, some side effects were reported more frequently in children and adolescents than in adults, e.g., muscle pain, pain in extremity, fatigue, and joint pain. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. In order to improve the traceability of this medicine, your doctor or pharmacist should record the name and the lot number of the product you have been given in your patient file. You may also wish to make a note of these details in case you are asked for this information in the future.
The tamper evident cap has been broken. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What AVONEX contains The active substanceis: Interferon beta-1a 30 micrograms/0.5 ml The other ingredients are: Sodium acetate, trihydrate; acetic acid glacial, arginine hydrochloride, polysorbate 20 and water for injections. What AVONEX looks like and contents of the pack Avonex solution for injection comes as a ready to use injection In a box of Avonex there are four or twelve ready to use (pre-filled) syringes, each with 0.5 ml of a clear, colourless liquid inside. Not all pack sizes may be marketed. Each syringe is packed in a sealed plastic tray. A separate needle to give the injection is also included in the tray. Marketing Authorisation Holder and Manufacturer The Marketing Authorisation Holder is: Biogen Netherlands B.V. Prins Mauritslaan 1171 LP Badhoevedorp The Netherlands Avonex is made by: FUJIFILM Diosynth Biotechnologies Denmark ApS Biotek All 1, DK-3400 Hiller d, Denmark Biogen Netherlands B.V. Prins Mauritslaan 1171 LP Badhoevedorp The Netherlands You can get a larger print version of this leaflet by calling the local representatives. For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
Belgi /Belgique/Belgien Biogen Belgium NV/SA +32 2 2191Lietuva Biogen Lithuania UAB +370 5 259 6
+359 2 962 12 Luxembourg/Luxemburg Biogen Belgium NV/SA +32 2 2191 esk republika Biogen (Czech Republic) s.r.o. +420 255 706 Magyarorsz g Biogen Hungary Kft. +36 1 899 9Danmark Biogen Denmark A/S +45 77 41 57 Malta Pharma. MT Ltd.. +356 21337Deutschland Biogen GmbH +49 (0) 89 99 6Nederland Biogen Netherlands B.V. +31 20 542 2Eesti Biogen Estonia O +372 618 9Norge Biogen Norway AS +47 23 40 01
Genesis Pharma SA +30 210 8771 sterreich Biogen Austria GmbH +43 1 484 46 Espa a Biogen Spain S.L. +34 91 310 7Polska Biogen Poland Sp. z o.o. +48 22 351 51 France Biogen France SAS +33 (0)1 41 37 9Portugal Biogen Portugal Sociedade Farmac utica, Unipessoal Lda. +351 21 318 8Hrvatska Biogen Pharma d.o.o. +385 1 775 73 Rom nia Johnson & Johnson Romania S.R.L. +40 21 207 18 Ireland Biogen Idec (Ireland) Ltd. +353 (0)1 463 7Slovenija Biogen Pharma d.o.o. +386 1 511 02 sland Icepharma hf +354 540 8Slovensk republika Biogen Slovakia s.r.o. +421 2 323 34Italia Biogen Italia s.r.l. +39 02 584 9Suomi/Finland Biogen Finland Oy +358 207 401
Genesis Pharma Cyprus Ltd +357 22 76 57 Sverige Biogen Sweden AB +46 8 594 113 Latvija Biogen Latvia SIA +371 68 688 United Kingdom (Northern Ireland) Biogen Idec (Ireland) Limited +44 (0) 1628 50 1This leaflet was last revised in Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-36f1b29a7444210831ac7deab30ae673
Resource Composition:
Generated Narrative: Composition composition-en-36f1b29a7444210831ac7deab30ae673
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/97/033/003status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - avonex
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp36f1b29a7444210831ac7deab30ae673
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp36f1b29a7444210831ac7deab30ae673
identifier:
http://ema.europa.eu/identifier
/EU/1/97/033/003type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: AVONEX 30 micrograms/0.5 ml solution for injection.
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en